Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation

被引:25
作者
Barel, MT
Pizzato, N
Le Bouteiller, P
Wiertz, EJHJ
Lenfant, F
机构
[1] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 RC Leiden, Netherlands
[2] Hop Purpan, INSERM, U563, CPTP, F-31024 Toulouse 3, France
关键词
cytomegalovirus; HLA-E; immune evasion; US;
D O I
10.1093/intimm/dxh362
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human cytomegalovirus (HCMV) interferes with cellular immune responses by modulating surface expression of MHC class I molecules. Here, we focused on HCMV-encoded unique short (US) 2 and US11, which bind newly synthesized MHC class I heavy chains (HCs) and support their dislocation into the cytosol for subsequent degradation by proteasomes. Not all MHC class I locus products are equally sensitive to this down-modulation. The aim of this study was to identify which domains, and ultimately which residues, are responsible for the resistance or sensitivity of MHC class I molecules to US2- and US11-mediated down-regulation. We show that, besides endoplasmic reticulum-lumenal regions, the C-terminus of class I molecules represents an important determinant for allele specificity in US11-mediated degradation. HLA-E becomes sensitive to US11-mediated down-regulation when its cytoplasmic tail is extended. Interestingly, this only requires two additional residues, lysine and valine, at its C-terminus. For US2, the MHC class I allele specificity is largely determined by a small region at the junction of the alpha 2/alpha 3 domain of the HC. It is quite remarkable that minor changes, in only four residues, can completely revert the sensitivity of naturally US2-resistant HLA-E molecules. With this study we provide better insights into the features underlying the selectivity in MHC class I down-regulation by US2 and US11.
引用
收藏
页码:173 / 182
页数:10
相关论文
共 44 条
[31]   Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion [J].
Park, BY ;
Kim, YK ;
Shin, JW ;
Lee, S ;
Cho, KM ;
Früh, K ;
Lee, S ;
Ahn, KS .
IMMUNITY, 2004, 20 (01) :71-85
[32]   KSHV-K5 inhibits phosphorylation of the major histocompatibility complex class I cytoplasmic tail [J].
Paulson, E ;
Tran, C ;
Collins, K ;
Früh, K .
VIROLOGY, 2001, 288 (02) :369-378
[33]  
Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]
[34]  
SANTOSAGUADO J, 1988, J IMMUNOL, V141, P2811
[35]   The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate [J].
Shamu, CE ;
Story, CM ;
Rapoport, TA ;
Ploegh, HL .
JOURNAL OF CELL BIOLOGY, 1999, 147 (01) :45-57
[36]   Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol [J].
Shamu, CE ;
Flierman, D ;
Ploegh, HL ;
Rapoport, TA ;
Chau, V .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (08) :2546-2555
[37]   TRANSFECTION OF MURINE LMTK- CELLS WITH PURIFIED HLA CLASS-I GENES .7. ASSOCIATION OF ALLELE-SPECIFIC AND LOCUS-SPECIFIC SEROLOGICAL REACTIVITIES WITH RESPECTIVELY THE 1ST AND 2ND DOMAINS OF THE HLA-B7 MOLECULE [J].
SODOYER, R ;
KAHNPERLES, B ;
STRACHAN, T ;
SIRE, J ;
SANTONI, MJ ;
LAYET, C ;
FERRIER, P ;
JORDAN, BR ;
LEMONNIER, FA .
IMMUNOGENETICS, 1986, 23 (04) :246-251
[38]   The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products [J].
Story, CM ;
Furman, MH ;
Ploegh, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (15) :8516-8521
[39]   Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141 [J].
Tomasec, P ;
Wang, ECY ;
Davison, AJ ;
Vojtesek, B ;
Armstrong, M ;
Griffin, C ;
McSharry, BP ;
Morris, RJ ;
Llewellyn-Lacey, S ;
Rickards, C ;
Nomoto, A ;
Sinzger, C ;
Wilkinson, GWG .
NATURE IMMUNOLOGY, 2005, 6 (02) :181-188
[40]   Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40 [J].
Tomasec, P ;
Braud, VM ;
Rickards, C ;
Powell, MB ;
McSharry, BP ;
Gadola, S ;
Cerundolo, V ;
Borysiewicz, LK ;
McMichael, AJ ;
Wilkinson, GWG .
SCIENCE, 2000, 287 (5455) :1031-1033